From December 4th to 5th, the 2024 (5th) China Cosmetics Annual Conference, hosted by PinGuan and CiE Beauty Innovation Exhibition, was held at the Guangzhou Baiyun International Convention Center & Yuexiu Marriott Hotel. As a leading enterprise in the domestic green active raw material field, Enzyme Products was invited to participate with its portfolio of star skincare products and delivered a keynote speech at the Raw Material Innovation Forum, discussing the driving forces for upward growth with industry peers.
1. Meeting venue
The enzyme products offer a comprehensive skincare solution with “one core, three factors, and eighteen peptides,” covering multiple series including facial care, eye care, and scalp care. They contain a variety of green active ingredients such as S -Pro-Xylane, green carnosine, acetyl hexapeptide-8, acetyl tetrapeptide-2, acetyl carnosine, acetyl hydroxyproline, and NAD+, providing customers with all-round scientific support and professional assurance for innovative products and business development.
2. Keynote speech
On December 5th, at the Raw Material Innovation Forum, a strategic collaboration between Enzyme Products, Dr. Fang Xin, Vice President of Enzyme Products and Senior Scientist, delivered a keynote speech entitled “Brand Power Through Cycles – The Third Wave of Pro-Xylane from a Positioning Perspective”.
Dr. Fang Xin began by introducing the Malik Curve: “Whether it’s an industry or a company, it will develop according to this curve. It starts relatively flat, then grows rapidly, then growth slows down, and finally enters a period of decline. Once an industry enters a period of slowing growth, involution is inevitable. The way for companies to break through this is to find a second growth curve and achieve a smooth transition. In today’s cosmetics industry, the focus of brand owners is no longer limited to product development or channel management, but rather on its core focus—how to get the product and brand into the customer’s mind and become the first choice. In the field of functional skincare, the best way to enter the customer’s mind is through various active ingredients, such as Pro-Xylane.”
Regarding Pro-Xylane, one of the three giants in anti-aging, Dr. Fang Xin shared the three waves this well-known raw material has experienced: the era of original research, the era of domestic alternatives, and the era of innovation. With the launch of the second-generation enzymatic S -Pro-Xylane, Dr. Fang Xin believes that the third wave of Pro-Xylane has arrived, and now is a good time for brands to “climb the ladder.” “Whether it’s market education, the stability, safety, and mechanism of action of the substance itself, or the green synthesis process, it can be applied to a variety of scenarios, from eye cream to body lotion. As the process continues to mature, its cost is also decreasing, and its application scenarios are constantly expanding.”
Dr. Fang Xin stated that, having experienced the first two waves of education, brands can leverage the advantage of Pro-Xylane already occupying consumers’ minds and use the second-generation enzymatic S -Pro-Xylane to achieve product differentiation and continuously create windows to enter consumers’ minds.
3. Regarding finished enzyme products
Enzyme Products is committed to becoming a global leader in green active ingredients , employing next-generation synthetic biology technologies to focus on the green production of active ingredients such as peptides, proteins, sugars, and nucleic acids. Leveraging over 20 years of research and industry experience accumulated by its founding team, the company has established a leading multidisciplinary technology platform in China. It has now achieved mass production of dozens of green active ingredients, including Smegglutinin, Telborpeptide, S -Pros-Xylane, NAD+, Blue Copper Peptide, HMOs, and various peptides. It has cumulatively provided high-quality green active ingredients to over a thousand well-known companies in the fields of biopharmaceuticals, functional skincare, nutritional health, and pet and animal health .
After seven years of rapid development, the company has achieved a leading position among global companies of its kind in terms of R&D investment, scale, and output. It has applied for more than 150 invention patents and has won more than ten national and local titles, including National Specialized and Innovative Small Giant, National High-tech Enterprise, Shenzhen Specialized and Innovative Small and Medium Enterprise, Shenzhen Potential Unicorn Enterprise, Guangdong Postdoctoral Innovation Practice Base, Shenzhen Top 30 Medical and Health Innovation Team, Zhuhai Innovation and Entrepreneurship Team, and Gansu Specialized and Innovative Small and Medium Enterprise. In 2022, it was selected as one of Shenzhen’s Top 100 High-Growth Enterprises (ranked first among unlisted biotech companies), and in 2023, it was selected as a Harvard Business Review High-Energy Innovation Team.